amygdalin has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, J; Sun, K; Tang, D; Wang, R; Wu, Y; Yin, S; Zhang, D; Zhu, W | 1 |
| Deng, J; Deng, S; Hao, E; Huang, X; Lei, T; Lv, J; Sun, M; Wang, H; Wang, Y; Wang, Z; Xiong, W | 1 |
| Moyad, MA | 1 |
1 review(s) available for amygdalin and Disease Exacerbation
| Article | Year |
|---|---|
Results and lessons from clinical trials using dietary supplements for cancer: direct and indirect investigations.
Topics: Acetylcysteine; Amygdalin; Antioxidants; Ascorbic Acid; beta Carotene; Dietary Supplements; Disease Progression; Humans; Neoplasms; Randomized Controlled Trials as Topic; Selenium; Tissue Extracts; Vitamin A; Vitamin E | 2001 |
2 other study(ies) available for amygdalin and Disease Exacerbation
| Article | Year |
|---|---|
Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2/STAT3 signaling pathway.
Topics: Aged; Amygdalin; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Coculture Techniques; Cytokines; Disease Progression; Female; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Janus Kinase 2; Liver Neoplasms; Male; Middle Aged; Signal Transduction; STAT3 Transcription Factor; T-Lymphocytes | 2021 |
Amygdalin ameliorates the progression of atherosclerosis in LDL receptor‑deficient mice.
Topics: Amygdalin; Animals; Atherosclerosis; Biomarkers; Cytokines; Disease Models, Animal; Disease Progression; Lipid Metabolism; Male; Mice; Mice, Knockout; Receptors, LDL; RNA, Messenger; T-Lymphocytes, Regulatory | 2017 |